Laboratory Analyst; GMP, Experimental; Cell Therapy

Laboratory Analyst (GMP, Experimental) (Cell Therapy)

Laboratory Analyst (GMP, Experimental) (Cell Therapy)

Our mission is to harness the immune system through innovative cell therapies and other modalities to deliver widely accessible cures. Patients are waiting!

• Responsible for cell and gene therapy manufacturing under GMP conditions.
• Carry out tests in compliance with GMP and safety rules.
• Process results (control, analysis, validation) and present them.
• Manage documentation in accordance with procedures.
• Draft laboratory notebooks and Dakota manage log‑books, including necessary actions for any observed anomalies.
• Participate in managing laboratory activities (reagent management, equipment monitoring) and in scaling‑up, transfer, development, process improvement projects, training, and seminars.

At least 2‑3 years of experience in the laboratory in an academic, clinical, or commercial setting.

BS/BA തിര_required.

Nexcella, Inc. is a subsidiary of Immix Biopharma, Inc. (Immix Bio) (Nasdaq: IMMX), a clinical‑stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases. Our lead candidate is a sterically‑optimised BCMA‑targeted chimeric antigen receptor T (CAR‑T) cell therapy NXC‑201 with a “digital filter” that filters out non‑specific activation. NXC‑201 is being evaluated in the U.S. multi‑center study for relapsed/refractory AL Amyloidosis NEXICART‑2 (NCT).

Interim results were presented at ASCO 2025. NXC‑201 has been awarded Regenerative Medicine Advanced Therapy (RMAT) by the US FDA and Orphan Drug Designation (ODD) by the FDA, and in the EU by the EMA. Learn more at  and

Entry level

Full‑time

Research, Analyst, and Information Technology